Matches in Nanopublications for { ?s ?p "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP381489.RAdgQSUSssLIekiNRPwdzcFVTT0WgsArg3DFi9w-TzqA4130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381489.RAdgQSUSssLIekiNRPwdzcFVTT0WgsArg3DFi9w-TzqA4130_provenance.
- assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1146507.RAVV9IW197Q4h1OGRXvGRR1G91nfip7FuCnMcrcl9z4dg130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1146507.RAVV9IW197Q4h1OGRXvGRR1G91nfip7FuCnMcrcl9z4dg130_provenance.
- NP1146511.RAQRQl_u2BR2ajjyU561EISl2MB5zzjw5ADMU7IqG74GA130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1146511.RAQRQl_u2BR2ajjyU561EISl2MB5zzjw5ADMU7IqG74GA130_provenance.
- NP676435.RApjpYSe6A_yQ5ZpKP0cJqtPG2ZSdakRhHY_qXbCzND3s130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676435.RApjpYSe6A_yQ5ZpKP0cJqtPG2ZSdakRhHY_qXbCzND3s130_provenance.
- NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_provenance.
- NP1146509.RAnUtRePmD2uEtqMgMCWwoXfSkJbZqgFstZ80GsDrKToE130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1146509.RAnUtRePmD2uEtqMgMCWwoXfSkJbZqgFstZ80GsDrKToE130_provenance.
- NP1146510.RAlExcatsodmPAC8_D9H1m34VI4E4hxEvhkfhhMLe59bg130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1146510.RAlExcatsodmPAC8_D9H1m34VI4E4hxEvhkfhhMLe59bg130_provenance.
- NP1146512.RAl4pAYOUekTShYjL2aIroGSFrVzhLn4lCXCY94y2CP1A130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1146512.RAl4pAYOUekTShYjL2aIroGSFrVzhLn4lCXCY94y2CP1A130_provenance.
- NP381595.RA3Drz3VaACJUT0_RAFTY_5uYZuvXtLZL4osvhKkTWim4130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381595.RA3Drz3VaACJUT0_RAFTY_5uYZuvXtLZL4osvhKkTWim4130_provenance.
- NP381259.RAKVrn8n_pdxjHcbjvb-XSm_2LUxQEpVdZdXOALUF0X4E130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381259.RAKVrn8n_pdxjHcbjvb-XSm_2LUxQEpVdZdXOALUF0X4E130_provenance.